Publication | Closed Access

Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: Clinical outcome according to KRAS and BRAF mutational status

Irinotecan FailureGastrointestinal OncologyMedicinePathologyColorectal CancerCancer TreatmentBraf Mutational StatusOncologyRadiation OncologyClinical OutcomeMolecular Oncology